Kevin Zikaras
Corporate Officer/Principal bei TCR2 THERAPEUTICS INC.
Aktive Positionen von Kevin Zikaras
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | 01.06.2018 | - |
Karriereverlauf von Kevin Zikaras
Ehemalige bekannte Positionen von Kevin Zikaras
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Kevin Zikaras
| Bowdoin College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
| Weill Cornell Medical College | Graduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Corporate Officer/Principal | 3 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Kevin Zikaras
- Erfahrung
